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The implication is
that racial classifi-
cations convey some
underlying genetic/
genomic uniqueness
to a group of people
that clearly distin-
guishes them from
others. The extent
to which such dif-
ferences exist, and
their clinical im-
portance, remains a
source of consider-
able debate . . .Recently, my attention was again drawn to the issue of the relevance and impor-tance of racial and geographical designations in medicine and, in fact, in societyin general. The San Diego community has come together for a joint effort to
ncrease the percentage of patients receiving appropriate therapy for hypertension, hyper-
ipidemia, and other atherosclerotic risk factors. At a recent meeting, we were addressed
y an African-American physician who stressed the importance of race and place in
erms of achieving guideline-prescribed goals for these risk factors. His presentation
rompted me to revisit the controversy of whether, independent of the socioeconomic
nd cultural variables, either of these characteristics, but particularly race, is of value in
elineating propensity to disease or response to treatment.
As I delved into the literature, it soon became obvious that confusion existed in re-
ard to several of the terms often used to classify patients, such as race, ethnicity, and
ncestry. So, I went to the Merriam-Webster dictionary, where I found that the defini-
ion of race was “a family, tribe, people, or nation belonging to the same stock” (1). This
esignation is somewhat nonspecific, and has multiple cultural and genetic implications.
n fact, the most common basis for racial designation that I have encountered is pheno-
ype, such as skin color. Obviously, genetic classification should be more important. It
eemed that genetic implications might be better conveyed by the term ethnicity, where
thnic is defined as “of or relating to large groups of people classed according to common
acial, national, tribal, religious, linguistic, or cultural origin or background” (1). Since
his still did not fully convey the genetic characteristics that would be important, it oc-
urred to me that the term ancestry might be more relevant to medicine. The dictionary
efinition for ancestry is “line of descent or lineage” (1), and this term seems to best
epresent the important differences in groups of individuals that could influence their
isk of disease or response to therapy. Nevertheless, race is the term that remains most
ommonly used in daily life.
Despite the confusion of these terms, the designation of race has come to occupy
n important place in everyday medicine. Patients are typically described as African
merican, Asian, or Hispanic in histories and physicals. It is recognized that many
onogenic diseases are more prevalent or nearly exclusively present in some racial/ethnic
roups. A variable response to therapy has been described for racial groups, particularly
n regard to hypertension and heart failure in African Americans. The implication is that
acial classifications convey some underlying genetic/genomic uniqueness to a group of
eople that clearly distinguishes them from others. The extent to which such differences
xist, and their clinical importance, remains a source of considerable debate, and the lit-
rature about this is more extensive than I had ever realized.
The relationship between race and ancestry can be quite variable (2). Genetic variance
as been estimated by ancestry informative markers and expressed by a statistical met-
ic called Wright’s Fixation Index. Based upon these analyses, genetic variance be-
ween sub-Saharan Africans, Northern Europeans, and East Asians is only 5% to
1827JACC Vol. 58, No. 17, 2011 DeMaria
October 18, 2011:1826–7 Editor’s Page15%. Data derived from several studies indicates that
the West African contribution to the ancestry of indi-
vidual African Americans ranges from 20% to 100%,
with an average of 20% from non-West African
sources. Similarly, approximately 30% of European
Americans have been estimated to have more than 10%
non-European ancestry. Accordingly, there is often a sig-
nificant difference between race, usually categorized by
phenotype and geography, and ancestry represented by
genotype.
Some have argued that, despite the genetic imprecision
of racial designation, race remains an important character-
istic from a medical perspective (3). They point out that
the over 85% of the genetic variance that exists is between
individuals of a given race, and only 15% or so exist be-
tween races. They emphasize that the lack of interbreed-
ing that resulted in the formation of human subgroups
was largely due to geography. The proponents of the rele-
vance of race emphasize that the risk of disease is due not
only to genetics, but also to environment, and that race is
a strong surrogate for the latter. From a practical stand-
point, most Americans identify with a single race, and
detailed genetic characterization would require sophisti-
cated and expensive testing.
In contrast to the above, we have now entered the era
of personalized medicine, and the focus has gone from
populations to individuals. The ultimate goal now is to
identify the genome of every individual so as to predict
his or her risk of disease and response to therapy. The
human genome has been sequenced, and genome-wide
association studies have identified a number of alleles that
convey risk or pharmacogenomic characteristics. Given
the predominance of genetic variation within races rather
than between races, it would be expected that the impor-
tance of race would be diminished. In any event, those
genetic differences related to race would, of course, be delin-
eated in the course of examining the individual genome.
It seems apparent that the definition of the specific
genome is clearly the most scientifically accurate andmedically valuable method to classify an individual.
However, environmental factors clearly play an important
role in determining a person’s health. The socioeconomic
and cultural variables that distinguish individuals are not
infrequently of greater impact on their health than any ge-
netic factors. In as much as race is often closely related to
these environmental considerations, it is of some value in
characterizing people. However, given the large percentage
of genetic variability within individual races, the smaller ge-
netic variability between races, and the substantial intermix-
ing of the gene pool between races, the implications of phe-
notype are limited in their value to distinguish ancestry.
Given the above, one can reasonably ask if there is any
reason to specify race as a subgroup in any study. Stated
another way, does the color of someone’s skin indicate
much of substantial importance regarding his or her risk
of disease or response to therapy? In most cases, the an-
swer is likely to be no. If it does have significance, it is
more likely to be related to environment than racial ge-
netics. In medicine, as in life in general, the races are in-
trinsically much, much more like each other than they are
different.
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